NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Coherence Neuro

Coherence Neuro

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.coherenceneuro.com/

Last Round

Seed

Nov 4, 2025

Est. Valuation

$40M

Total Funding Raised

$16.92M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Coherence Neuro is a medical technology company that designs therapeutic neurotechnology to manage cancer from inside the body.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Medical AI, Clinical Trials, Health IoT

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

brain-computer interfaceBCIcancer treatmentimplantable medical deviceglioblastoma treatmentbrain implantbioelectronic medicineneurotechnologyneuromodulationclosed-loop therapyelectroceuticalstumor treating fieldsprecision medicinesoftware as a therapydigital therapeutics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Coherence Neuro Comps

Public and private peers based on sector, stage, and business model.

Coherence Neuro comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Coherence Neuro Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 4, 2025
Pre SeedApr 28, 2023
Pre SeedMar 13, 2023
GrantAug 3, 2022

Key People

Founding team and executive leadership

Elise Jenkins

Co-Founder, CTO

Founding Team

Ben Woodington

CEO Co-Founder

Founding Team

Coherence Neuro Investors

Notable investors and investment history

Coherence Neuro investors
InvestorRounds
Spacewalk VCSeed
Xtal VenturesSeed
ArtesianSeed
Cancer Research UKGrant
SmartGateVCSeed
Possible VenturesSeed, Pre Seed
Jumpspace VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 5, 2026

    Grew 24% QoQ, from 21 to 26 employees.

  • Apr 22, 2026

    Grew 42% QoQ from 19 to 27 employees.

Coherence Neuro Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Coherence Neuro Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Coherence Neuro's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range26
Year Founded2022
Last FundingNov 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.